Popular / View All Posts

Journal of Drugs in Dermatology JDD Article about Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

| Dyspigmentation, Featured Articles, Latest News | No Comments
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025  article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations...

New Innovations of SkinCeuticals and Antioxidants Review

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
JDD Multimedia Love28 New Innovations of SkinCeuticals and Antioxidants Review Join Dr. Jared Jagdeo, a board certified dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Jagdeo will present...

Optimizing Patient Outcomes with Adjunctive OTC Skincare​

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
JDD Multimedia Love27 Optimizing Patient Outcomes with Adjunctive OTC Skincare Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative...
Journal of Drugs in Dermatology JDD Article about Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

| Derm Community, Featured Articles, Latest News | No Comments
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the...